semaglutide push health compounded Novo Nordisk calls out dangers of GLP-1s in new ad Hims & Hers offers compounded Australian doctors are pushing for

Key takeaways Low-dose IGF-1 LR3 infusion did not improve beta cell growth or function in models of fetal growth restriction (FGR) caused by placental insufficiency

However, definitive evidence from adequately powered human trials demonstrating cognitive benefits is still lacking, and ongoing phase 3 studies are investigating these potential effects

While LBM loss appears to be less pronounced than FBM loss in many studies, the clinical significance of even modest reductions in skeletal muscle remains uncertain, particularly in older adults or individuals at risk of sarcopenia

Next year it will be the next injectable

Nat Rev Cardiol 2018